Skip to main content
The NCI Community Hub will be retiring in May 2024. For more information please visit the NCIHub Retirement Page:

NCL Method GTA-2

By Stephan Stern, Pavan Adiseshaiah, Timothy Potter

Hep G2 Hepatocarcinoma Cytotoxicity Assay

Listed in Datasets | publication by group NCL Protocols

Version 2.0b - published on 09 Jul 2020 doi:10.17917/96Z2-NZ61 - cite this

Licensed under these terms


This protocol describes the cytotoxicity testing of nanoparticle formulations in human hepatocarcinoma cells (Hep G2), as part of the in vitro NCL preclinical characterization cascade. The protocol utilizes two methods for estimation of cytotoxicity, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction and lactate dehydrogenase (LDH) release.

Content List

Cite this work

Researchers should cite this work as follows:



Powered by ...

NCL Protocols

NCL Protocols group image

When watching a publication, you will be notified when a new version is released.